Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07279740
PHASE2

Combined Brain Stimulation and Methylphenidate Treatment for Apathy in Dementia

Sponsor: Sunnybrook Health Sciences Centre

View on ClinicalTrials.gov

Summary

This study evaluates whether the combined treatment of methylphenidate and non-invasive brain stimulation, called intermittent theta burst stimulation, can effectively treat apathy in individuals with Alzheimer's disease or mixed AD/vascular dementia

Official title: Methylphenidate Primed iTBS for Apathy in Neurocognitive Disorders

Key Details

Gender

All

Age Range

Any - Any

Study Type

INTERVENTIONAL

Enrollment

12

Start Date

2026-01

Completion Date

2027-10-01

Last Updated

2025-12-12

Healthy Volunteers

No

Interventions

DEVICE

intermittent theta burst stimulation (iTBS)

iTBS is a form of repetitive transcranial magnetic simulation (rTMS), a non-invasive form of brain stimulation.

DRUG

Methylphenidate (MPH)

Participants will be on methylphenidate clinically prior to the trial

Locations (1)

Sunnybrook Research Institute

Toronto, Ontario, Canada